Home > Qtrly Results > LINCOLN PHARMACEUTICALS

LINCOLN PHARMACEUTICALS
Quarterly Results Analysis [Dec2023]

LINCOLN PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for LINCOLN PHARMACEUTICALS
Please provide your vote to see the results

LINCOLN PHARMACEUTICALS Quarterly Results

Consolidated Dec2023
UnAudited
Sep2023
UnAudited
Jun2023
UnAudited
Mar2023
Audited
Dec2022
UnAudited
Sep2022
UnAudited
Jun2022
UnAudited
Mar2022
Audited
Revenues ₹146 Cr ₹156 Cr ₹136 Cr ₹112 Cr ₹134 Cr ₹141 Cr ₹123 Cr ₹103 Cr
Expenses ₹117 Cr ₹125 Cr ₹115 Cr ₹96 Cr ₹107 Cr ₹112 Cr ₹107 Cr ₹85 Cr
Operating Income ₹30 Cr ₹31 Cr ₹21 Cr ₹17 Cr ₹27 Cr ₹29 Cr ₹17 Cr ₹17 Cr
Other Income ₹11 Cr ₹9 Cr ₹8 Cr ₹4 Cr ₹6 Cr ₹6 Cr ₹6 Cr ₹2 Cr
Interest ₹0 Cr ₹0 Cr ₹0 Cr ₹1 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹1 Cr
Depreciation ₹3 Cr ₹3 Cr ₹3 Cr ₹2 Cr ₹2 Cr ₹2 Cr ₹2 Cr ₹2 Cr
Profit Before Tax ₹38 Cr ₹37 Cr ₹25 Cr ₹17 Cr ₹31 Cr ₹32 Cr ₹21 Cr ₹17 Cr
Profit After Tax ₹28 Cr ₹28 Cr ₹19 Cr ₹13 Cr ₹22 Cr ₹24 Cr ₹15 Cr ₹11 Cr
EPS ₹14.00 ₹13.81 ₹9.49 ₹6.27 ₹10.79 ₹11.84 ₹7.49 ₹5.50
Industry Peers & Returns1W1M1Y
LINCOLN PHARMACEUTICALS 5.6% -17.6% 72.6%
SUN PHARMACEUTICAL INDUSTRIES 3% 2.3% 68.2%
CIPLA 2.5% 0.4% 71.7%
DR REDDYS LABORATORIES -0.2% -4.9% 40.3%
ZYDUS LIFESCIENCES 5% 10.4% 109.1%
DIVIS LABORATORIES -1.6% -7% 23.8%
MANKIND PHARMA NA NA NA
TORRENT PHARMACEUTICALS 2.9% -2.2% 69%
LUPIN 2.8% 0% 147.8%

LINCOLN PHARMACEUTICALS Quarterly Revenues

Revenues
Q-o-Q

-6.12 %

Y-o-Y

9.48 %

Quarters Revenues % Change
Dec2023 ₹146 Cr
-6.12
Sep2023 ₹156 Cr
15.02
Jun2023 ₹136 Cr
20.59
Mar2023 ₹112 Cr
-15.93
Dec2022 ₹134 Cr
-4.87
Sep2022 ₹141 Cr
13.88
Jun2022 ₹123 Cr
20.36
Mar2022 ₹103 Cr -

LINCOLN PHARMACEUTICALS Quarterly Operating Profit

Operating Profit
Q-o-Q

-4.78 %

Y-o-Y

10.87 %

Quarters Operating Profit % Change
Dec2023 ₹30 Cr
-4.78
Sep2023 ₹31 Cr
50.34
Jun2023 ₹21 Cr
24.51
Mar2023 ₹17 Cr
-37.80
Dec2022 ₹27 Cr
-7.44
Sep2022 ₹29 Cr
70.89
Jun2022 ₹17 Cr
-3.06
Mar2022 ₹17 Cr -
Operating Margins
Q-o-Q

1.40 %

Y-o-Y

1.25 %

Quarters Operating Margin% % Change
Dec2023 20.25%
1.40
Sep2023 19.97%
30.69
Jun2023 15.28%
3.24
Mar2023 14.8%
-26.00
Dec2022 20%
-2.68
Sep2022 20.55%
50.00
Jun2022 13.7%
-19.46
Mar2022 17.01% -

LINCOLN PHARMACEUTICALS Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

1.39 %

Y-o-Y

29.73 %

Quarters Profit After Tax % Change
Dec2023 ₹28 Cr
1.39
Sep2023 ₹28 Cr
45.44
Jun2023 ₹19 Cr
51.36
Mar2023 ₹13 Cr
-41.88
Dec2022 ₹22 Cr
-8.86
Sep2022 ₹24 Cr
57.95
Jun2022 ₹15 Cr
36.17
Mar2022 ₹11 Cr -
PAT Margins
Q-o-Q

8.01 %

Y-o-Y

18.50 %

Quarters PAT Margin(%) % Change
Dec2023 19.15 %
8.01
Sep2023 17.73 %
26.46
Jun2023 14.02 %
25.51
Mar2023 11.17 %
-30.88
Dec2022 16.16 %
-4.15
Sep2022 16.86 %
38.65
Jun2022 12.16 %
13.12
Mar2022 10.75 % -

LINCOLN PHARMACEUTICALS Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

1.38 %

Y-o-Y

29.75 %

Quarters EPS % Change
Dec2023 ₹14
1.38
Sep2023 ₹13.81
45.52
Jun2023 ₹9.49
51.36
Mar2023 ₹6.27
-41.89
Dec2022 ₹10.79
-8.87
Sep2022 ₹11.84
58.08
Jun2022 ₹7.49
36.18
Mar2022 ₹5.5 -

You may also like the below Video Courses